Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population

Journal of the American Academy of Dermatology

Volumn 66, Issue 2, 2012, Pages

  Papp, Kim A ^a   Poulin, Yves ^b   Bissonnette, Robert ^c   Bourcier, Marc ^d   Toth, Darryl ^e   Rosoph, Leslie ^f   Poulin Costello, Melanie ^g   Setterfield, Mike ^g   Syrotuik, Jerry ^g  

^a Probity Medical Research   (United States)

^b Centre Dermatologique du Quebec Metropolitain   (Canada)

^c INNOVADERM RESEARCH   (Canada)

^d Dermatology Clinic   (Canada)

^e XLR8 Medical Research   (Canada)

^f North Bay Dermatology Centre   (Canada)

^g Amgen Canada Inc   (Canada)

Author keywords

biological therapy; etanercept; psoriasis; safety; tumor necrosis factor

Indexed keywords

CORTICOSTEROID; ETANERCEPT; PLACEBO; PSORALEN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BASAL CELL CARCINOMA; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DATA ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LONG TERM CARE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYOSITIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PHOTOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; RATING SCALE; RHINOPHARYNGITIS; SEPTIC SHOCK; TREATMENT DURATION; ULTRAVIOLET A RADIATION; UNSTABLE ANGINA PECTORIS; UPPER RESPIRATORY TRACT INFECTION;

ADULT; AGED; DRUG TOXICITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFECTION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; QUALITY OF LIFE; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 84855835696     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.07.026     Document Type: Article

References (21)

1. A. Mussi, C. Bonifati, M. Carducci, G. D'Agosto, F. Pimpinelli, and D. D'Urso Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis J Biol Regul Homeost Agents 11 1997 115 118 (Pubitemid 28045966)
2. Enbrel [product monograph]. Mississauga, Canada: Amgen Canada Inc and Montréal, Canada: Pfizer Canada; 2010.
3. C.L. Leonardi, J.L. Powers, R.T. Matheson, B.S. Goffe, R. Zitnik, and A. Wang Etanercept as monotherapy in patients with psoriasis N Engl J Med 349 2003 2014 2022 (Pubitemid 37448924)
4. K.A. Papp, S. Tyring, M. Lahfa, J. Prinz, C.E.M. Griffiths, and A.M. Nakanishi A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction Br J Dermatol 152 2005 1304 1312 (Pubitemid 40933433)
5. B. Elewski, C. Leonardi, A.B. Gottlieb, B.E. Strober, M.A. Simiens, and M. Dunn Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis Br J Dermatol 156 2007 138 142 (Pubitemid 44924157)
6. C. Leonardi, B. Strober, A.B. Gottlieb, B.E. Elewski, J.P. Ortonne, and P. van der Kerkhof Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study J Drugs Dermatol 9 2010 928 937
7. S. Tyring, A. Gottlieb, K. Papp, K. Gordon, C. Leonardi, and A. Wang Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomized phase III trial Lancet 367 2006 29 35 (Pubitemid 43038667)
8. S. Tyring, K.B. Gordon, Y. Poulin, R. Langley, A.B. Gottlieb, and M. Dunn Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis Arch Dermatol 143 2007 719 726 (Pubitemid 46955730)
9. Papp K, Bissonette R, Syrotuik J, Poulin-Costello M, Luong T. Assessment of the long-term safety of etanercept for the treatment of psoriasis in an adult Canadian population [abstract]. Paris, France: 17th Congress of European Academy of Dermatology and Venereology, September 17-21, 2008. Abstract 1771. EADV 2008.
10. K. Papp, R. Bissonette, T. Luong, and Y. Poulin Assessment of the long-term safety and efficacy of etanercept for the treatment of psoriasis in an adult Canadian population [abstract] J Am Acad Dermatol 60 2009 AB165 Abstract P3314
11. A.Y. Finlay, and G.K. Khan Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use Clin Exp Dermatol 19 1994 210 216 (Pubitemid 24194579)
12. A. Agresti Categorical Data Analysis 2nd ed. 2002 John Wiley & Sons Inc. Hoboken, New Jersey
13. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) program. SEER® Stat database: incidence-SEER 13 regs public-use, November 2004 submission for expanded races (1992-2002), DCCPS, surveillance research program, cancer statistics branch. Released April 2005, based on the November 2004 submission. Available from: URL: http://www.seer.cancer.gov/.
14. R.B. Harris, K. Griffith, and T.E. Moon Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996 J Am Acad Dermatol 45 2001 528 536 (Pubitemid 32917246)
15. D.T. Gray, V.J. Suman, W.P. Su, R.P. Clay, W.S. Harmsen, and R.K. Roenigk Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992 Arch Dermatol 133 1997 735 740 (Pubitemid 27263707)
16. R.G. Langley, and C.N. Ellis Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment J Am Acad Dermatol 51 2004 563 569 (Pubitemid 39278075)
17. A. Menter, S.K. Tyring, K. Gordon, A.B. Kimball, C.L. Leonardi, and R.G. Langley Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial J Am Acad Dermatol 58 2008 106 115 (Pubitemid 350298146)
18. C.L. Leonardi, A.B. Kimball, K.A. Papp, N. Yeilding, C. Guzzo, and Y. Wang Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1) Lancet 371 2008 1665 1674 (Pubitemid 351671883)
19. G. Frentz, and J.H. Olsen Malignant tumors and psoriasis: a follow-up study Br J Dermatol 140 1999 237 242 (Pubitemid 29111349)
20. D. Margolis, W. Bilker, S. Hennessy, C. Vittorio, J. Santanna, and B.L. Strom The risk of malignancy associated with psoriasis Arch Dermatol 137 2001 778 783 (Pubitemid 32577862)
21. J.M. Gelfand, A.L. Neimann, D.B. Shin, X Wang, DJ Margolis, and A.B. Troxel Risk of myocardial infarction in patients with psoriasis JAMA 296 2006 1735 1741 (Pubitemid 44547793)